Community For this strata a single study (n=20) reported all-cause mortality alone. The evidence was very low quality and did not demonstrate a clear effect with the confidence interval ranging from a decrease and increase in all-cause mortality. Mixed For the outcome all-cause mortality, 8 studies (n=2360) were included. The evidence was low quality and did not demonstrate a clear effect with the confidence interval ranging from a decrease and increase in all-cause mortality The outcome all-cause hospitalisation contained 6 studies (n=2052) was also low quality and showed no clinical effect. This outcome was also subject to heterogeneity =55%), unexplained by subgroup analysis for age which was taken into consideration when judging the quality of the evidence. For the outcome QoL the evidence ranged from low to very low quality. Depending on the scale used the clinical outcome varied. For the physical functioning component of the SF-36 there was evidence of a clinically important improvement in QoL. However, for the mental component summary there was evidence of a clinically important reduction in QoL. For the scale MLWHF there was no evidence of a clinical effect. Telemonitoring + structured telephone support Recent admission A single study (n=1437) looked at the effect of telemonitoring in addition to structured telephone support. For the outcome all-cause mortality (low quality) there was evidence of a clinically important reduction in deaths. For the outcome all-cause hospitalisations (moderate quality) there was evidence of a clinically important increase in hospitalisations. For the outcome QoL (low quality) the MLWHF showed no clinical effect. Economic One cost utility analysis found that home telemonitoring was cost effective compared to usual care, structured telephone support (human-to-machine interface), and structured telephone support (human-to-human interface) for managing heart failure (ICER: 6,616 per QALY gained compared to usual care). 